The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pacira BioSciences Inc shares valued at $16,174 were sold by SLONIN JONATHAN on Jan 06 ’25. At $18.40 per share, SLONIN JONATHAN sold 879 shares. The insider’s holdings dropped to 93,444 shares worth approximately $2.18 million following the completion of this transaction.
Also, SLONIN JONATHAN purchased 879 shares, netting a total of over 16,174 in proceeds.
Before that, GAUGLER DARYL had sold 500 shares from its account. In a trade valued at $9,880, the Chief Operating Officer traded Pacira BioSciences Inc shares for $19.76 each. Upon closing the transaction, the insider’s holdings decreased to 500 shares, worth approximately $2.69 million.
As published in a research note from Truist on August 13, 2024, Pacira BioSciences Inc [PCRX] has been rated down from a Buy to a Sell and the price target has been revised to $8 from $30. Analysts at RBC Capital Mkts downgraded the stock from ‘”an Outperform”‘ to ‘”a Sector perform”‘ outlook in a report released in mid August. As of August 12, 2024, Raymond James has decreased its “an Outperform” rating to a “Mkt perform” for PCRX. Earlier on August 12, 2024, Piper Sandler downgraded its rating. Their new recommendation was “a Neutral” for PCRX stock which previously was a “an Overweight”.
Analyzing PCRX Stock Performance
During the last five days, there has been a surge of approximately 6.63%. Over the course of the year, Pacira BioSciences Inc shares have jumped approximately 23.83%. Shares of the company reached a 52-week high of $23.51 on 01/23/25 and a 52-week low of $18.17 on 01/06/25. A 50-day SMA is recorded $18.95, while a 200-day SMA reached $20.79. Nevertheless, trading volume fell to 1.27 million shares from 0.48 million shares the previous day.
Support And Resistance Levels for Pacira BioSciences Inc (PCRX)
According to the 24-hour chart, there is a support level at 22.55, which, if violated, would cause prices to drop to 21.78. In the upper region, resistance lies at 23.81. The next price resistance is at 24.29. RSI (Relative Strength Index) is 72.60 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.17, which suggests the price will increase in the coming days. Percent R is at 3.37%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
